Top Stories
Nasdaq Wins SEC Support for Plan to Diversify Company Boards
Vivia Chen: Associates Want to Return to the Office—With Caveats
Despite all the resistance young lawyers have shown about marching back to the office, some are not automatically dissing it. But it comes with a price—and it’s not money.
Activision Hit With Derivative Suit Over Sexual Harassment
An
HHS Proposes Nixing Trump Rule Tying Drug Costs to Foreign Rates
The Health and Human Services Department on Friday proposed to withdraw a Trump-era drug payment model tying U.S. costs to foreign prices.
‘Solid’ Biden Vehicle Emission Proposal Still Open to Lawsuits
The Biden administration’s carefully unveiled plans for tighter vehicle emission rules appear more resistant to major litigation but aren’t immune to lawsuits, lawyers and policy experts say.
Teva ‘Skinny Label’ Ruling Comes Amid Lawmaker Drug Cost Fight
Republican and Democratic lawmakers trying to push down prescription drug prices may have just had a wrench thrown into their efforts thanks to a federal appellate court, following a decision legal experts say will make it more complicated for generics to enter the marketplace.
Cleveland Roller Derby Guardians Set Up MLB Trademark Showdown
The Cleveland Guardians roller derby team responded to the Cleveland Indians’ decision to re-brand itself the Guardians not with public comment but with a trademark application.











